Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular genotyping: development and limits].

M Delpech1

  • 1Laboratoire de biochimie et génétique moléculaire, hôpital Cochin, 123, boulevard de Port-Royal, 75014, Paris, France. secretariat.delpech@cch.ap-hop-paris.fr <secretariat.delpech@cch.ap-hop-paris.fr>

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|June 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France.

Annals of the rheumatic diseases·2010
Same author

[Cancer genetics: estimation of the needs of the population in France for the next ten years].

Bulletin du cancer·2009
Same author

Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.

Rheumatology (Oxford, England)·2007
Same author

Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.

Annals of the rheumatic diseases·2006
Same author

[Genetic testing, the legal setting in France and Europe].

Annales d'endocrinologie·2005
Same author

Upregulation of rat P23 (a member of the YjgF protein family) by fasting, glucose diet and fatty acid feeding.

Cellular and molecular life sciences : CMLS·2004
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

Molecular genotyping kits are essential for medical diagnosis. Future advancements like DNA chips promise improved diagnostics but face high cost challenges.

Area of Science:

  • Molecular biology
  • Genetics
  • Biotechnology

Context:

  • Molecular genotyping kits are currently used for diagnostic purposes.
  • Traditional reverse dot-blot methods are being superseded by advanced technologies.

Purpose:

  • To discuss the evolution of molecular genotyping technologies.
  • To highlight the potential of micro-arrays and DNA chips for medical diagnostics.

Summary:

  • Commercially available molecular genotyping kits are vital for diagnostics.
  • Future diagnostic systems will likely involve micro-arrays, DNA chips, and Labs on a Chip.
  • Current high costs of these advanced systems present a significant barrier.

Impact:

  • The transition to advanced genotyping technologies could revolutionize medical diagnostics.

Related Experiment Videos

  • Addressing the cost barrier is crucial for widespread adoption of next-generation diagnostic tools.